Education
About Us
Working with TipRanks
Follow Us
Denice Torres Insider Profile
4 Followers
Denice Torres, Director at Bluebird Bio, holds 21.71K shares in Glaukos (Ticker: GKOS), holds 31.56K shares in 2seventy bio (Ticker: TSVT), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX).
Denice Torres Bluebird Bio (BLUE)Director
Bluebird Bio (BLUE)
Director
Not Ranked
Denice Torres has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Denice Torres
Denice Torres's Trading History
Bluebird Bio
Nov 17, 2021
―
Uninformative Buy
―
$13.55K
Karuna Therapeutics
Mar 18, 2024
―
Uninformative Sell
326.70K
$0.00
Glaukos
Jun 02, 2025
Director
Uninformative Buy
―
$2.10M
Surface Oncology
―
―
―
―
2seventy bio
Jun 12, 2024
―
Uninformative Buy
―
$157.80K
Celldex
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Denice Torres's performance on stock
You May Also Like
Denice Torres insider profile FAQ
What is the percentage of profitable transactions made by Denice Torres?
The percentage of profitable transactions made by Denice Torres is ―.
What is the average return per transaction made by Denice Torres?
The average return per transaction made by Denice Torres is ―.
What stocks does Denice Torres hold?
Denice Torres holds: BLUE, KRTX, GKOS, SURF, TSVT, CLDX stocks.
What was Denice Torres’s latest transaction?
Denice Torres latest transaction was an Uninformative Buy of ―.
What was Denice Torres's most profitable transaction?
Denice Torres’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Denice Torres's role in Bluebird Bio?
Denice Torres's role in Bluebird Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.